Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Hypertension: a new perspective in therapy and metabolic effect. Part i

Medina Ruiz, A.

Boletin de la Asociacion Medica de Puerto Rico 83(9): 399-401

1991

ISSN/ISBN: 0004-4849
PMID: 1807274
Document Number: 700169
Antihypertensive Therapy has been ineffective in reducing the incidence of coronary artery disease. It has been suggested that the metabolic and biochemical alterations induced by some antihypertensive drugs may be responsible for their failure to reduce cardiovascular mortality in patients with hypertension. Hypertension is only one of multiple coronary risk factors associated to insulin resistance. This cluster of risk factors is call "The Syndrome of Insulin Resistance" by some and "Syndrome X" by Reaven and others. Is important to know this information when pharmacological antihypertensive therapy is contemplated.

Document emailed within 1 workday
Secure & encrypted payments

Hypertension: a new perspective in therapy and metabolic effect. Part i

Os, I.; Hjermann, I.; Nordby, G. 1991: Hypertension as a part of metabolic cardiovascular syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(25): 3062-3064
Khan, N.A.; McAlister, F.A.; Lewanczuk, R.Z.; Touyz, R.M.; Padwal, R.; Rabkin, S.W.; Leiter, L.A.; Lebel, M.; Herbert, C.; Schiffrin, E.L.; Herman, R.J.; Hamet, P.; Fodor, G.; Carruthers, G.; Culleton, B.; DeChamplain, J.; Pylypchuk, G.; Logan, A.G.; Gledhill, N.; Petrella, R.; Campbell, N.R.C.; Arnold, M.; Moe, G.; Hill, M.D.; Jones, C.; Larochelle, P.; Ogilvie, R.I.; Tobe, S.; Houlden, R.; Burgess, E.; Feldman, R.D. 2005: The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy Canadian Journal of Cardiology 21(8): 657-672
Cloutier, L.; Leclerc, A.-M.; Longpré, S.; Nahro, M. 2013: Drug therapy of hypertension. Part 1 Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 10(1): 36-41
McAlister, F.A.; Zarnke, K.B.; Campbell, N.R.C.; Feldman, R.D.; Levine, M.; Mahon, J.; Grover, S.A.; Lewanczuk, R.; Leenen, F.; Tobe, S.; Lebel, M.; Stone, J.; Schiffrin, E.L.; Rabkin, S.W.; Ogilvie, R.I.; Larochelle, P.; Jones, C.; Honos, G.; Fodor, G.; Burgess, E.; Hamet, P.; Herman, R.; Irvine, J.; Culleton, B.; Wright, J.M. 2002: The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy Canadian Journal of Cardiology 18(6): 625-641
Werning, C.; Stiel, D.; Hammann, K.; Schweikert, H.U.; Fischer, N.; Siegenthaler, W. 1972: SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension Fortschritte der Medizin 90(20): 785-787
Malishevskiĭ, M.V.; Zhmurov, V.A.; Gapon, L.I.; Kashuba, E.A.; Argunova, G.A. 1993: The effect of the physical status of the neutrophil membranes on their functional metabolic activity in hypertension patients Kardiologiia 33(11): 13-16; 3
Knypl, K.; Brym, E.; Czerniewska, E.; Wocial, B.; Kuczyńska, K.; Chodakowska, J. 1991: Effect of long-term prazosin treatment on certain humoral and metabolic factors in patients with primary hypertension Polski Tygodnik Lekarski 46(1-3): 32-34
Müting, D. 1978: Metabolic risk factors and their field of action. Incidence and therapy of hypertension, hyperuricemia, hyperlipidemia, diabetes mellitus, nicotine and alcohol abuse and obesity Fortschritte der Medizin 96(25): 1319-1322
Tiwaskar, M. 2016: Hypertension Control in India: Are we there Yet? OR Uncontrolled and Resistant Hypertension: the Indian Perspective Journal of the Association of Physicians of India 64(7): 11-12
Landry, F.; Jetté, M.; Blümchen, G. 1987: Exercise hypertension in the perspective of systemic arterial hypertension. An overview Herz 12(2): 75-82
Lim, T.O. 1991: The Mentakab Hypertension Project. Part IV--Hypertension care: is it adequate? a criterion-based audit of hypertension care in a hospital Singapore Medical Journal 32(6): 431-433
Efimov, A.S.; Ugarov, B.N.; Epshteĭn, E.V.; Zubkova, S.T.; Levenets, L.S.; Naumenko, V.G.; Efimov, D.A.; Danilova, A.I. 1991: The effect of microwave resonance therapy on the clinical and metabolic indices of diabetic patients Terapevticheskii Arkhiv 63(10): 51-54
Shen, C.-J.; Yin, Y.-Z.; Shu, R. 2008: The effect of initial periodontal therapy on metabolic control in type 2 diabetes mellitus Shanghai Kou Qiang Yi Xue 17(1): 6-9
Kornaga, E. 2001: The effect of hormonal replacement therapy on symptoms of climacteric syndrome and selected metabolic parameters Ginekologia Polska 72(3): 113-120
Mizock, B. 1984: Septic Shock. a metabolic perspective Archives of Internal Medicine 144(3): 579-585
Lim, T.O. 1992: The Mentakab Hypertension Study Project Part VI--Blood pressure measurement and hypertension: a questionnaire survey of medical staff Singapore Medical Journal 33(2): 160-163
Kuriata, A.V.; Karavanskaia, I.L.; Pavlichenko, N.A. 2010: Effect of metabolic therapy on the course of heart failure in patients after myocarditis complicated with systemic connecting tissue diseases Likars'ka Sprava 2010(5-6): 109-116
Pal, J.; Sen, K.; Sarkar, G.; Mandal, A.; Chakraborty, S.; Deb, A. 2013: Effect of antiretroviral therapy on pulmonary hypertension in HIV patients Journal of the Indian Medical Association 111(12): 845
Onyegbutulem, H.C.; H-Onyegbutulem, P.I.; Reimann, M.; Li, J.; Bornstein, S.R.; Schwarz, P.E. 2009: Metabolic syndrome in Africa: an emerging perspective Hormone and Metabolic Research 41(2): 75-78
Hemmelgarn, B.R.; Zarnke, K.B.; Campbell, N.R.C.; Feldman, R.D.; McKay, D.W.; McAlister, F.A.; Khan, N.; Schiffrin, E.L.; Myers, M.G.; Bolli, P.; Honos, G.; Lebel, M.; Levine, M.; Padwal, R. 2004: The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk Canadian Journal of Cardiology 20(1): 31-40